CDXS — Codexis Income Statement
0.000.00%
- $218.73m
- $161.32m
- $70.14m
- 36
- 23
- 60
- 34
Annual income statement for Codexis, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 68.5 | 69.1 | 105 | 139 | 70.1 |
Cost of Revenue | |||||
Gross Profit | 52.8 | 55.3 | 82.5 | 101 | 57.3 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 81 | 93 | 127 | 173 | 138 |
Operating Profit | -12.5 | -23.9 | -22.7 | -34.9 | -68.1 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -11.9 | -23.7 | -21.1 | -33.3 | -76.2 |
Provision for Income Taxes | |||||
Net Income After Taxes | -11.9 | -24 | -21.3 | -33.6 | -76.2 |
Net Income Before Extraordinary Items | |||||
Net Income | -11.9 | -24 | -21.3 | -33.6 | -76.2 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -11.9 | -24 | -21.3 | -33.6 | -76.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.211 | -0.404 | -0.33 | -0.483 | -0.992 |